Impairment of Myocardial Protection in Type 2 Diabetic Patients
- 1 February 2003
- journal article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 88 (2) , 531-537
- https://doi.org/10.1210/jc.2002-020904
Abstract
Diabetic patients are more prone to develop postinfarction complications. It remained unclear whether diabetes mellitus- or sulfonylureas-associated changes of ATP-sensitive potassium (K(ATP)) channels, an integral player in ischemic preconditioning, are responsible for the increased mortality. The purpose of this study was to determine the impact of diabetes mellitus per se and different sulfonylurea administration on cardioprotective effects in diabetic patients undergoing coronary angioplasty. Myocardial ischemia after coronary angioplasty was evaluated in 20 nondiabetic and 23 diabetic patients chronically taking either glibenclamide or glimepiride. Nondiabetic patients treated with glimepiride significantly lowered the ischemic burden assessed by an ST-segment shift, chest pain score, and myocardial lactate extraction ratios compared with the glibenclamide-treated patients, implying that acute administration of glimepiride did not abolish cardioprotection. In the diabetic glibenclamide-treated group, the reduction in the ST-segment shift afforded by nicorandil in the first inflation (-58% vs. the first inflation in the glibenclamide group alone) was similar to that afforded by preconditioning (-59% during the second vs. the first inflation). In glimepiride-treated groups, the magnitude of attenuated lactate production was less in diabetes than that in nondiabetes at the second inflation, suggesting that diabetes mellitus per se plays a role in determining lactate production. Our results show that both diabetes mellitus and sulfonylureas can act in synergism to inhibit activation of K(ATP) channels in patients undergoing coronary angioplasty. The degree of inhibition assessed by metabolic and electrocardiographic parameters is less severe during treatment with glimepiride than with glibenclamide. Restitution of a preconditioning response in glimepiride-treated patients may be the potential beneficial mechanism.Keywords
This publication has 34 references indexed in Scilit:
- Differential Effects of Sarcolemmal and Mitochondrial KATP Channels Activated by 17β-Estradiol on Reperfusion Arrhythmias and Infarct Sizes in Canine HeartsThe Journal of Pharmacology and Experimental Therapeutics, 2002
- A Conserved Inhibitory and Differential Stimulatory Action of Nucleotides on KIR6.0/SUR Complexes Is Essential for Excitation-Metabolism Coupling by KATP ChannelsJournal of Biological Chemistry, 2001
- Failure to precondition pathological human myocardiumJournal of the American College of Cardiology, 2001
- The effect of glibenclamide on the production of interstitial adenosine by inhibiting ecto-5′-nucleotidase in rat heartsBritish Journal of Pharmacology, 1997
- Cardiovascular Effects of Conventional Sulfonylureas and GlimepirideHormone and Metabolic Research, 1996
- Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor I. Binding characteristicsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1994
- Effects of ionic and nonionic contrast media on coronary diameter and blood flow in chronically instrumented dogsAmerican Heart Journal, 1989
- The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosisJournal of the American College of Cardiology, 1989
- MEASUREMENT OF PAINPublished by Elsevier ,1974
- MYOCARDIAL INFARCTION IN MATURITY-ONSET DIABETICS: A Retrospective StudyThe Lancet, 1972